Structure and Activation Mechanism of the CHK2 DNA Damage Checkpoint Kinase

被引:146
作者
Cai, Zhenjian [1 ]
Chehab, Nabil H. [1 ]
Pavletich, Nikola P. [1 ,2 ]
机构
[1] Mem Sloan Kettering Canc Ctr, Struct Biol Program, New York, NY 10021 USA
[2] Mem Sloan Kettering Canc Ctr, Howard Hughes Med Inst, New York, NY 10021 USA
关键词
DOUBLE-STRAND BREAKS; PROTEIN-KINASE; THREONINE-68; PHOSPHORYLATION; IONIZING-RADIATION; CANCER RISK; MUTATIONS; OLIGOMERIZATION; DOMAIN; CHEK2-ASTERISK-1100DELC; SUSCEPTIBILITY;
D O I
10.1016/j.molcel.2009.09.007
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
The CHK2 protein kinase is an important transducer of DNA damage checkpoint signals, and its mutation contributes to hereditary and sporadic cancer. CHK2 activation is triggered by the phosphorylation of Thr68 by the DNA damage-activated ATM kinase. This leads to transient CHK2 dimerization, in part through intermolecular phosphoThr68-FHA domain interactions. Dimerization promotes kinase activation through activation-loop auto phosphorylation, but the mechanism of this process has not been clear. The dimeric crystal structure of CHK2, described here, in conjunction with biochemical and mutational data reveals that productive CHK2 dimerization additionally involves intermolecular FHA-kinase domain and FHA-FHA interactions. Ile157, mutated in the Li-Fraumeni cancer-pred is position syndrome, plays a central role in the FHA-kinase domain interface, explaining the lack of dimerization and autophosphorylation of this mutant. In the dimer, the kinase active sites face each other in close proximity, indicating that dimerization may also serve to optimally position the kinase active sites for efficient activation loop transphosphorylation.
引用
收藏
页码:818 / 829
页数:12
相关论文
共 48 条
  • [1] The Chk2 protein kinase
    Ahn, J
    Urist, M
    Prives, C
    [J]. DNA REPAIR, 2004, 3 (8-9) : 1039 - 1047
  • [2] Checkpoint kinase 2 (Chk2) monomers or dimers phosphorylate Cdc25C after DNA damage regardless of threonine 68 phosphorylation
    Ahn, J
    Prives, C
    [J]. JOURNAL OF BIOLOGICAL CHEMISTRY, 2002, 277 (50) : 48418 - 48426
  • [3] Questioning the role of checkpoint kinase 2 in the p53 DNA damage response
    Ahn, JW
    Urist, M
    Prives, C
    [J]. JOURNAL OF BIOLOGICAL CHEMISTRY, 2003, 278 (23) : 20480 - 20489
  • [4] Phosphorylation of threonine 68 promotes oligomerization and autophosphorylation of the Chk2 protein kinase via the forkhead-associated domain
    Ahn, JY
    Li, XH
    Davis, HL
    Canman, CE
    [J]. JOURNAL OF BIOLOGICAL CHEMISTRY, 2002, 277 (22) : 19389 - 19395
  • [5] Ahn JY, 2000, CANCER RES, V60, P5934
  • [6] Analysis of CHK2 in patients with myelodysplastic syndromes
    Aktas, D
    Arno, MJ
    Rassool, F
    Mufti, GJ
    [J]. LEUKEMIA RESEARCH, 2002, 26 (11) : 985 - 987
  • [7] CHK2 kinase: cancer susceptibility and cancer therapy - two sides of the same coin?
    Antoni, Laurent
    Sodha, Nayanta
    Collins, Ian
    Garrett, Michelle D.
    [J]. NATURE REVIEWS CANCER, 2007, 7 (12) : 925 - 936
  • [8] Chk1 and Chk2 kinases in checkpoint control and cancer
    Bartek, J
    Lukas, J
    [J]. CANCER CELL, 2003, 3 (05) : 421 - 429
  • [9] Heterozygous germ line hCHK2 mutations in Li-Fraumeni syndrome
    Bell, DW
    Varley, JM
    Szydlo, TE
    Kang, DH
    Wahrer, DCR
    Shannon, KE
    Lubratovich, M
    Verselis, SJ
    Isselbacher, KJ
    Fraumeni, JF
    Birch, JM
    Li, FP
    Garber, JE
    Haber, DA
    [J]. SCIENCE, 1999, 286 (5449) : 2528 - 2531
  • [10] Generation, representation and flow of phase information in structure determination:: recent developments in and around SHARP 2.0
    Bricogne, G
    Vonrhein, C
    Flensburg, C
    Schiltz, M
    Paciorek, W
    [J]. ACTA CRYSTALLOGRAPHICA SECTION D-BIOLOGICAL CRYSTALLOGRAPHY, 2003, 59 : 2023 - 2030